Nevro Corp. is a healthcare company based in the United States. They specialize in medical devices, with their main product being the HFX spinal cord stimulation (SCS) platform, including the Senza SCS system. This system uses electrical impulses to alleviate chronic pain and is implanted by physicians but controlled by patients. Nevro Corp. generates most of its revenue in the U.S. and has a medium-risk ESG score of 21.9.